Live donor kidney - PAK versus SPK: how to decide?

Area of Science:

• Nephrology
• Transplantation
• Endocrinology

Background:

• Type 1 diabetes and end-stage renal disease (ESRD) present complex treatment challenges.
• Kidney transplantation is a common treatment for ESRD, but managing concurrent diabetes requires specialized approaches.

Purpose of the Study:

• To review and compare outcomes of simultaneous kidney pancreas transplant (SPK), kidney transplant alone, and pancreas after kidney transplant (PAK).
• To inform treatment decisions for patients with type 1 diabetes and ESRD undergoing kidney transplantation.

Main Methods:

• Systematic literature review of studies on SPK, kidney transplant alone, and PAK.
• Analysis of patient and graft survival rates.
• Examination of pre- and post-transplant variables impacting outcomes.

Main Results:

• Simultaneous kidney pancreas transplant (SPK) is associated with optimal long-term patient survival.
• The choice between SPK and living donor kidney transplant with potential PAK is less clear.
• Various pre- and post-transplant factors influence patient and graft survival.

Conclusions:

• SPK is generally the preferred option for long-term survival in type 1 diabetes patients with ESRD.
• Individualized assessment of risks and benefits is crucial when considering different transplant strategies.
• Further research may clarify optimal pathways for patients considering living donor kidney transplant with potential PAK.